Company Filing History:
Years Active: 2016-2018
Title: Brandee Wagner: Innovator in Metabolic Disorders
Introduction: Brandee Wagner is an accomplished inventor based in La Jolla, California, known for her significant contributions to the field of medicine through her innovative research. With a total of three patents to her name, Brandee is making strides in the treatment of metabolic disorders, showcasing her expertise and dedication to developing impactful solutions.
Latest Patents: Two of her latest patents focus on targeting microRNAs for metabolic disorders. These patents describe compounds comprising modified oligonucleotides that are complementary to miR-103 and/or miR-107. The methods outlined in these patents promise innovative approaches to treating diseases and disorders associated with these microRNAs, paving the way for new therapeutic options for patients.
Career Highlights: Brandee currently works with Regulus Therapeutics Inc., a company dedicated to discovering and developing innovative medicines based on the regulation of microRNAs. Under her stewardship, brandee has contributed to advancing the scientific understanding of metabolic disorders and their treatment options.
Collaborations: In her career, Brandee has collaborated with several notable professionals, including colleagues Balkrishen Bhat and Neil W Gibson. Together, they contribute to a dynamic research environment aimed at fostering innovative solutions in the biotechnology field.
Conclusion: Brandee Wagner's work and inventions represent a significant advancement in the understanding and treatment of metabolic disorders. Through her patents and collaborations at Regulus Therapeutics Inc., she exemplifies the spirit of innovation, contributing to a brighter future in the healthcare landscape.